|
UA73073C2
(uk)
*
|
1997-04-03 |
2005-06-15 |
Уайт Холдінгз Корпорейшн |
Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція
|
|
US6002008A
(en)
*
|
1997-04-03 |
1999-12-14 |
American Cyanamid Company |
Substituted 3-cyano quinolines
|
|
AUPP003197A0
(en)
*
|
1997-09-03 |
1997-11-20 |
Fujisawa Pharmaceutical Co., Ltd. |
New heterocyclic compounds
|
|
EP1072263A4
(en)
|
1998-03-26 |
2004-03-31 |
Japan Tobacco Inc |
AMID DERIVATIVES AND NOCICEPTINANT AGONISTS
|
|
US7045519B2
(en)
|
1998-06-19 |
2006-05-16 |
Chiron Corporation |
Inhibitors of glycogen synthase kinase 3
|
|
GB9822440D0
(en)
|
1998-10-14 |
1998-12-09 |
Smithkline Beecham Plc |
Medicaments
|
|
AU5250400A
(en)
*
|
1999-06-18 |
2001-01-09 |
Mitsubishi Pharma Corporation |
Osteogenesis promoters
|
|
WO2001017562A1
(fr)
*
|
1999-09-02 |
2001-03-15 |
Yamanouchi Pharmaceutical Co., Ltd. |
Agents promoteurs de l'osteogenese
|
|
SE9903611D0
(sv)
*
|
1999-10-06 |
1999-10-06 |
Astra Ab |
Novel compounds III
|
|
ES2349762T3
(es)
*
|
2000-08-10 |
2011-01-11 |
Pfizer Italia S.R.L. |
Biciclo-pirazoles activos como inhibidores de quinasas, procedimientos para su preparación y composiciones farmacéuticas que los comprenden.
|
|
DE10060145C1
(de)
*
|
2000-12-04 |
2002-06-13 |
Michael Wackernagel |
Chinolin-Derivate, ihre Verwendung und diese enthaltende pharmazeutische Zusammensetzung
|
|
IL156315A0
(en)
*
|
2000-12-07 |
2004-01-04 |
Cv Therapeutics Inc |
Abca-1 elevating compounds
|
|
AR038658A1
(es)
*
|
2001-06-15 |
2005-01-26 |
Novartis Ag |
Derivados de 4-aril-2(1h) quinazolinona y 4-aril-quinazolina 2-sustituidas, un proceso para su preparacion, composiciones farmaceuticas y el uso de dichos derivados para la preparacion de un medicamento
|
|
GB0130341D0
(en)
*
|
2001-12-19 |
2002-02-06 |
Smithkline Beecham Plc |
Compounds
|
|
GB0230015D0
(en)
*
|
2002-12-23 |
2003-01-29 |
Novartis Ag |
Organic compounds
|
|
UA80607C2
(en)
*
|
2003-04-09 |
2007-10-10 |
White Holdings Corp |
Process for the preparation of 3-cyano-6-alkoxy-7-nitro-4-quinolines
|
|
DE10331675A1
(de)
*
|
2003-07-14 |
2005-02-10 |
Bayer Cropscience Ag |
Hetarylsubstituierte Pyrazolidindion-Derivate
|
|
BRPI0415179A
(pt)
|
2003-10-07 |
2006-11-28 |
Renovis Inc |
derivados de amida como ligandos de canal de ìon e composições farmacêuticas e métodos de empregar as mesmas
|
|
CN1972688B
(zh)
*
|
2004-05-06 |
2012-06-27 |
沃尼尔·朗伯有限责任公司 |
4-苯胺基-喹唑啉-6-基-酰胺类化合物
|
|
WO2005108404A1
(ja)
*
|
2004-05-12 |
2005-11-17 |
Ube Industries, Ltd. |
エチニル基置換縮合ヘテロ環化合物重金属錯体、その製造法、その合成中間体及びその製造法並びに有機エレクトロルミネッセンス素子
|
|
FR2873695A1
(fr)
*
|
2004-07-30 |
2006-02-03 |
Palumed Sa |
Molecules hybrides qa ou q est une aminoquinoleine et a est un antibiotique ou un inhibiteur de resistance), leur synthese et leurs utilisations en tant qu'agent antibacterien
|
|
FR2874922A1
(fr)
*
|
2004-07-30 |
2006-03-10 |
Palumed Sa |
Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien
|
|
EP1771456A2
(fr)
*
|
2004-07-30 |
2007-04-11 |
Palumed SA |
Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien
|
|
WO2006040645A1
(en)
*
|
2004-10-11 |
2006-04-20 |
Ranbaxy Laboratories Limited |
N-(3,5-dichloropyridin-4-yl)-2,4,5-alkoxy and 2,3,4-alkoxy benzamide derivatives as pde-iv (phophodiesterase type-iv) inhibitors for the treatment of inflammatory diseases such as asthma
|
|
US7875627B2
(en)
|
2004-12-07 |
2011-01-25 |
Abbott Laboratories |
Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof
|
|
US7576099B2
(en)
|
2005-02-28 |
2009-08-18 |
Renovis, Inc. |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
|
|
BRPI0607404A2
(pt)
|
2005-03-01 |
2009-09-01 |
Wyeth Corp |
compostos de cinolina e seu uso como moduladores de receptor de x hepático
|
|
WO2006093253A1
(ja)
*
|
2005-03-03 |
2006-09-08 |
Santen Pharmaceutical Co., Ltd. |
キノリルアルキルチオ基を有する新規環式化合物
|
|
MX2008010671A
(es)
*
|
2006-02-21 |
2008-10-01 |
Amgen Inc |
Derivados de cinolina como inhibidores de fosfodiesterasa 10.
|
|
US20090099175A1
(en)
*
|
2006-03-01 |
2009-04-16 |
Arrington Mark P |
Phosphodiesterase 10 inhibitors
|
|
US20070299067A1
(en)
*
|
2006-03-08 |
2007-12-27 |
Ruiping Liu |
Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors
|
|
MX2009012117A
(es)
*
|
2007-05-09 |
2009-11-23 |
Pfizer |
Composiciones y derivados heterociclicos sustituidos y su uso farmaceutico como antibacterianos.
|
|
WO2010144611A2
(en)
*
|
2009-06-10 |
2010-12-16 |
3-V Biosciences, Inc. |
Antivirals that target transporters, carriers, and ion channels
|
|
CN103539734B
(zh)
*
|
2013-09-25 |
2015-10-14 |
上海交通大学 |
3-烯丙基喹啉的制备方法
|
|
US20200347038A1
(en)
|
2014-08-29 |
2020-11-05 |
Russell Dahl |
Quinolines that modulate serca and their use for treating disease
|
|
WO2016032569A1
(en)
*
|
2014-08-29 |
2016-03-03 |
Celladon Corporation |
Quinolines and their use for treating endoplasmic reticulum stress-caused diseases
|
|
US9932310B2
(en)
*
|
2016-02-08 |
2018-04-03 |
City Of Hope |
DNA2 inhibitors for cancer treatment
|
|
US11730729B2
(en)
|
2020-07-20 |
2023-08-22 |
Neurodon Corporation |
Quinolines that modulate SERCA and their use for treating disease
|
|
US12486269B2
(en)
|
2024-02-08 |
2025-12-02 |
Aconcagua Bio, Inc. |
Compounds and compositions for treating conditions associated with calcitonin receptor and/or amylin receptor activity
|
|
WO2025171341A2
(en)
*
|
2024-02-08 |
2025-08-14 |
Aconcagua Bio, Inc. |
Compounds and compositions for treating conditions associated with calcitonin receptor and/or amylin receptor activity
|